Key Questions on PARP Inhibitors in Ovarian Cancer: Experts Evaluate the Latest Evidence

In this interactive recording of a live CCO webinar experts discuss the latest data on safely and effectively leveraging PARP inhibitors for treating patients with ovarian cancer. Download the slides for use in your own presentations!

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca